Al-Razi Medical Co.
Al-Razi Medical Co. (9572.SR) Revenue
Annual & quarterly revenue history · segment & region breakdown
9572.SR · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsAl-Razi Medical Co. trailing twelve-month (TTM) revenue is $0.14B, an increase of 21.24% year-over-year from $0.07B in FY2025.
Revenue trend
2025 – 2021 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.07B | +$0.01B | +21.24% |
| 2024-12-31 | $0.06B | +$0.00B | +0.03% |
| 2023-12-31 | $0.06B | +$0.01B | +17.07% |
| 2022-12-31 | $0.05B | +$0.01B | +15.95% |
| 2021-12-31 | $0.05B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Al-Razi Medical Co. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Al-Razi Medical Co. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in SAR.
Data sourced from Al-Razi Medical Co.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
9572.SR revenue · 4 questions9572.SR's trailing twelve-month (TTM) revenue is $0.14B. That is an increase of 21.24% year-over-year from $0.07B in FY2025.
▸ Source: FMP · Al-Razi Medical Co. SEC filings · GAAP · Al-Razi Medical Co. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026